sf 20

Ambrisentan (BSF 208075) 是 ET A 型受体选择性拮抗剂。

Dactimicin is a novel pseudodisaccharide aminoglycoside. It has activities in vitro and in vivo antibacterial. Dactimicin was more resistant than astromicin to inactivation by aminoglycoside 3-acetyltransferase.

Dactimicin is a new aminoglycoside. It also has in vitro activity, post-antibiotic effect, and interaction with other antibiotics.

EGFR-IN-451 is an EGFR inhibitor, attenuating Ang II-induced Kidney Fibrosis.